These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9525603)

  • 1. Specific interactions between retrovirus Env and Gag proteins in rat neurons.
    Weclewicz K; Ekström M; Kristensson K; Garoff H
    J Virol; 1998 Apr; 72(4):2832-45. PubMed ID: 9525603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
    Ding SF; Lombardi R; Nazari R; Joshi S
    Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V; Muriaux D; Darlix JL; Cosset FL
    J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
    Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
    J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious particles derived from Semliki Forest virus vectors encoding murine leukemia virus envelopes.
    Lebedeva I; Fujita K; Nihrane A; Silver J
    J Virol; 1997 Sep; 71(9):7061-7. PubMed ID: 9261436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
    Song YE; Olinger GY; Janaka SK; Johnson MC
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of simian--human immunodeficiency virus-like particles.
    Yao Q; Kuhlmann FM; Eller R; Compans RW; Chen C
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):227-36. PubMed ID: 10710211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.
    Miller AD; Garcia JV; von Suhr N; Lynch CM; Wilson C; Eiden MV
    J Virol; 1991 May; 65(5):2220-4. PubMed ID: 1850008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors.
    Li KJ; Garoff H
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11658-63. PubMed ID: 8876192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of virus-like Semliki Forest virus replicon particles expressing Indian HIV-1C gag, env and polRT genes.
    Ajbani SP; Velhal SM; Kadam RB; Patel VV; Lundstrom K; Bandivdekar AH
    Immunol Lett; 2017 Oct; 190():221-232. PubMed ID: 28851629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.
    Gregory DA; Lyddon TD; Johnson MC
    J Virol; 2013 Feb; 87(3):1518-27. PubMed ID: 23152533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport and assembly of gag proteins into Moloney murine leukemia virus.
    Hansen M; Jelinek L; Whiting S; Barklis E
    J Virol; 1990 Nov; 64(11):5306-16. PubMed ID: 1698996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus.
    Suomalainen M; Garoff H
    J Virol; 1994 Aug; 68(8):4879-89. PubMed ID: 8035486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Env and Gag protein expression patterns and epitope availability in feline immunodeficiency virus infected PBMC compared to infected and transfected feline model cell lines.
    Roukaerts IDM; Grant CK; Theuns S; Christiaens I; Acar DD; Van Bockstael S; Desmarets LMB; Nauwynck HJ
    Virus Res; 2017 Jan; 227():249-260. PubMed ID: 27836726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice.
    Wong SB; Siliciano RF
    J Virol; 2005 Feb; 79(3):1701-12. PubMed ID: 15650195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of interactions between the Gag precursor proteins of murine leukemia viruses.
    Alin K; Goff SP
    Virology; 1996 Feb; 216(2):418-24. PubMed ID: 8607272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells.
    Voelkel C; Galla M; Dannhauser PN; Maetzig T; Sodeik B; Schambach A; Baum C
    Hum Gene Ther; 2012 Mar; 23(3):274-86. PubMed ID: 22010882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells.
    Chen BK; Rousso I; Shim S; Kim PS
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15239-44. PubMed ID: 11742097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L; Li Y; Cannon PM; Kim S; Kang CY
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.